Drug class
Thrombopoietin receptor agonist; oral platelet-production stimulator
Mechanism of action
Binds and activates the thrombopoietin receptor (c-Mpl) on haematopoietic stem cells and megakaryocyte progenitors, stimulating proliferation and differentiation and increasing platelet production.
General use cases
- Treatment of thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure
- Treatment of persistent or chronic immune thrombocytopenia (ITP) in adults with an insufficient response to previous treatment; use is product-specific and is not intended to normalise platelet counts
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
